Cargando…
Cell Therapy of Congenital Corneal Diseases with Umbilical Mesenchymal Stem Cells: Lumican Null Mice
BACKGROUND: Keratoplasty is the most effective treatment for corneal blindness, but suboptimal medical conditions and lack of qualified medical personnel and donated cornea often prevent the performance of corneal transplantation in developing countries. Our study aims to develop alternative treatme...
Autores principales: | Liu, Hongshan, Zhang, Jianhua, Liu, Chia-Yang, Wang, I-Jong, Sieber, Martin, Chang, John, Jester, James V., Kao, Winston W. Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873411/ https://www.ncbi.nlm.nih.gov/pubmed/20502663 http://dx.doi.org/10.1371/journal.pone.0010707 |
Ejemplares similares
-
Bone marrow mesenchymal stem cells can differentiate and assume corneal keratocyte phenotype
por: Liu, Hongshan, et al.
Publicado: (2012) -
Lumican Binds ALK5 to Promote Epithelium Wound Healing
por: Yamanaka, Osamu, et al.
Publicado: (2013) -
Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican
por: Chakravarti, Shukti, et al.
Publicado: (1998) -
Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
por: Call, Mindy, et al.
Publicado: (2019) -
Lumican Peptides: Rational Design Targeting ALK5/TGFBRI
por: Gesteira, Tarsis Ferreira, et al.
Publicado: (2017)